Functional MR imaging as a new paradigm for image guidance

[1]  Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.  A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular Carcinoma , 2009 .

[2]  G. Antoch,et al.  Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation : Initial results , 2008 .

[3]  A. Benson,et al.  Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. , 2008, Radiology.

[4]  Deniz Bilecen,et al.  MR-guided endovascular interventions: a comprehensive review on techniques and applications , 2008, European Radiology.

[5]  D. Collins,et al.  Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor , 2008, European Radiology.

[6]  Dingxin Wang,et al.  Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation. , 2008, Radiology.

[7]  K. Ahrar,et al.  Hepatic Arterial Embolization and Chemoembolization in the Management of Patients with Large-Volume Liver Metastases , 2008, CardioVascular and Interventional Radiology.

[8]  D. Madoff,et al.  Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. , 2007, Journal of vascular and interventional radiology : JVIR.

[9]  S. Taylor-Robinson,et al.  Cholangiocarcinoma and its management , 2007, Gut.

[10]  Andrew C Larson,et al.  Liver tumors: monitoring embolization in rabbits with VX2 tumors--transcatheter intraarterial first-pass perfusion MR imaging. , 2007, Radiology.

[11]  I. Kamel,et al.  Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. , 2007, Journal of vascular and interventional radiology : JVIR.

[12]  D. Collins,et al.  Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors , 2007, Journal of magnetic resonance imaging : JMRI.

[13]  Jianhua Jin,et al.  Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. , 2007, AJR. American journal of roentgenology.

[14]  F. Miller,et al.  Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. , 2007, AJR. American journal of roentgenology.

[15]  Zhenghan Yang,et al.  In vivo 1H MR spectroscopy in the evaluation of the serial development of hepatocarcinogenesis in an experimental rat model. , 2006, Academic radiology.

[16]  W. Peng,et al.  In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization. , 2006, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[17]  Aditya Bansal,et al.  Choline Transporter as a Novel Target for Molecular Imaging of Cancer , 2006, Molecular imaging.

[18]  I. Kamel,et al.  Assessment of tumor response on MR imaging after locoregional therapy. , 2006, Techniques in vascular and interventional radiology.

[19]  S Ekholm,et al.  Effects of number of diffusion gradient directions on derived diffusion tensor imaging indices in human brain. , 2006, AJNR. American journal of neuroradiology.

[20]  F. Miller,et al.  Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. , 2006, Journal of vascular and interventional radiology : JVIR.

[21]  Bradford A Moffat,et al.  The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. , 2006, Neoplasia.

[22]  D. Bluemke,et al.  The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. , 2006, Journal of vascular and interventional radiology : JVIR.

[23]  V. Goh,et al.  Imaging tumor angiogenesis: functional assessment using MDCT or MRI? , 2006, Abdominal Imaging.

[24]  Young Kon Kim,et al.  Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. , 2006, Radiology.

[25]  D. Santini,et al.  Endocrine pancreatic tumors: factors correlated with survival. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  T. Paunesku,et al.  Feasibility of blood oxygenation level-dependent MR imaging to monitor hepatic transcatheter arterial embolization in rabbits. , 2005, Journal of vascular and interventional radiology : JVIR.

[27]  K. Ahrar,et al.  Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors , 2005, Cancer.

[28]  Ravi Murthy,et al.  Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[29]  J. Norton.  Surgical treatment and prognosis of gastrinoma. , 2005, Best practice & research. Clinical gastroenterology.

[30]  J. Hanly,et al.  Management of neuropsychiatric lupus. , 2005, Best practice & research. Clinical rheumatology.

[31]  N. Heaton,et al.  Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. , 2005, Analytical chemistry.

[32]  Weijian Guo,et al.  Treatment for liver metastases from breast cancer: results and prognostic factors. , 2005, World journal of gastroenterology.

[33]  M. Knopp,et al.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations , 2005, British Journal of Cancer.

[34]  H. Pitt,et al.  Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival? , 2005, Annals of surgery.

[35]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Choti,et al.  Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. , 2005, Journal of vascular and interventional radiology : JVIR.

[37]  A. Padhani,et al.  Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging , 2005, Abdominal Imaging.

[38]  G. Johnson,et al.  Differentiating Surgical from Non-Surgical Lesions using Perfusion MR Imaging and Proton MR Spectroscopic Imaging , 2004, Technology in cancer research & treatment.

[39]  M. Soulen,et al.  Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. , 2004, Gastroenterology.

[40]  Y. Li,et al.  Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98. , 2004, World journal of gastroenterology.

[41]  Elmar Spuentrup,et al.  MR‐guided radiofrequency ablation of hepatic malignancies at 1.5 T: Initial results , 2004, Journal of magnetic resonance imaging : JMRI.

[42]  Glyn Johnson,et al.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.

[43]  D. Bluemke,et al.  Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. , 2003, AJR. American journal of roentgenology.

[44]  K. Ahrar,et al.  Hepatic Artery Embolization and Chemoembolization for Treatment of Patients with Metastatic Carcinoid Tumors: The M.D. Anderson Experience , 2003, Cancer journal.

[45]  Cedric X. Yu,et al.  Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. , 2003, Medical physics.

[46]  S. Goldberg,et al.  Minimally Invasive Image-Guided Therapies for Hepatocellular Carcinoma , 2002, Journal of clinical gastroenterology.

[47]  D. Bluemke,et al.  Magnetic resonance imaging of the liver: assessing response to treatment. , 2002, Topics in magnetic resonance imaging : TMRI.

[48]  Junji Konishi,et al.  Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. , 2002, Radiology.

[49]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[50]  G. Dodd,et al.  Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. , 2001, AJR. American journal of roentgenology.

[51]  D. Yeung,et al.  Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results. , 2001, Radiology.

[52]  S. Dwivedi,et al.  Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer , 2001, British Journal of Cancer.

[53]  C. Bartolozzi,et al.  Assessment of therapeutic effect of liver tumor ablation procedures. , 2001, Hepato-gastroenterology.

[54]  J. Buscombe,et al.  Treatment of hepatocellular carcinoma: a pivotal role for nuclear medicine? , 2001, Nuclear medicine communications.

[55]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[56]  M. Bronskill,et al.  Analysis of changes in MR properties of tissues after heat treatment , 1999, Magnetic resonance in medicine.

[57]  T. Livraghi,et al.  Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. , 1999, AJR. American journal of roentgenology.

[58]  T. Murakami,et al.  Diffusion-weighted single-shot echoplanar MR imaging for liver disease. , 1999, AJR. American journal of roentgenology.

[59]  L. Ellis,et al.  Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients , 1999 .

[60]  I. Yamada,et al.  Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. , 1999, Radiology.

[61]  B. Skogseid,et al.  Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors , 1998, Cancer.

[62]  J. Bruix,et al.  Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution , 1998, Hepatology.

[63]  F. Garbagnati,et al.  Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. , 1998, AJR. American journal of roentgenology.

[64]  G. Royle,et al.  Patterns of clinical metastasis in breast cancer: an analysis of 100 patients. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[65]  T. Matsumoto,et al.  Therapeutic Efficacy of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: MRI and Pathology , 1995, Journal of computer assisted tomography.

[66]  W. Ensminger,et al.  Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[67]  C. Bartolozzi,et al.  Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. , 1994, Radiology.

[68]  C. Tiribelli,et al.  Fatty Infiltration of the Liver: Quantification by 1H Localized Magnetic Resonance Spectroscopy and Comparison with Computed Tomography , 1993, Investigative radiology.

[69]  D. Nagorney,et al.  Cytoreductive hepatic surgery for neuroendocrine tumors. , 1990, Surgery.

[70]  A. Roche,et al.  A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. , 1990, Journal of hepatology.

[71]  J. Tsuruda,et al.  Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. , 1990, Radiology.

[72]  A. Parkin,et al.  Deranged liver blood flow patterns in the detection of liver metastases , 1985, The British journal of surgery.

[73]  D. Bluemke,et al.  Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. , 2008, AJR. American journal of roentgenology.

[74]  A. Gillams,et al.  Imaging appearances following thermal ablation. , 2008, Clinical radiology.

[75]  Sanjay Gupta,et al.  Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. , 2008, Journal of vascular and interventional radiology : JVIR.

[76]  D. Bluemke,et al.  Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. , 2007, Journal of vascular and interventional radiology : JVIR.

[77]  A. M. Gil,et al.  Metabolic profiling of liver from hypercholesterolemic pigs fed rye or wheat fiber and from normal pigs. High-resolution magic angle spinning 1H NMR spectroscopic study. , 2007, Analytical chemistry.

[78]  N. Gusani,et al.  Treatment of Unresectable Cholangiocarcinoma with Gemcitabine-Based Transcatheter Arterial Chemoembolization (TACE): A Single-Institution Experience , 2007, Journal of Gastrointestinal Surgery.

[79]  Jean-Luc Daire,et al.  Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. , 2003, Radiology.

[80]  T. de Baère,et al.  Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors , 2002, European Radiology.

[81]  W R Lees,et al.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[82]  C. Bartolozzi,et al.  Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. , 1995, Radiology.

[83]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.